These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 25701377

  • 1. Phosphopeptide interactions with BRCA1 BRCT domains: More than just a motif.
    Wu Q, Jubb H, Blundell TL.
    Prog Biophys Mol Biol; 2015 Mar; 117(2-3):143-148. PubMed ID: 25701377
    [Abstract] [Full Text] [Related]

  • 2. Structural basis for the BRCA1 BRCT interaction with the proteins ATRIP and BAAT1.
    Liu X, Ladias JA.
    Biochemistry; 2013 Oct 29; 52(43):7618-27. PubMed ID: 24073851
    [Abstract] [Full Text] [Related]

  • 3. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
    Rodriguez M, Yu X, Chen J, Songyang Z.
    J Biol Chem; 2003 Dec 26; 278(52):52914-8. PubMed ID: 14578343
    [Abstract] [Full Text] [Related]

  • 4. BRCT repeats as phosphopeptide-binding modules involved in protein targeting.
    Manke IA, Lowery DM, Nguyen A, Yaffe MB.
    Science; 2003 Oct 24; 302(5645):636-9. PubMed ID: 14576432
    [Abstract] [Full Text] [Related]

  • 5. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
    Williams RS, Lee MS, Hau DD, Glover JN.
    Nat Struct Mol Biol; 2004 Jun 24; 11(6):519-25. PubMed ID: 15133503
    [Abstract] [Full Text] [Related]

  • 6. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.
    Botuyan MV, Nominé Y, Yu X, Juranic N, Macura S, Chen J, Mer G.
    Structure; 2004 Jul 24; 12(7):1137-46. PubMed ID: 15242590
    [Abstract] [Full Text] [Related]

  • 7. BRCT domains: phosphopeptide binding and signaling modules.
    Rodriguez MC, Songyang Z.
    Front Biosci; 2008 May 01; 13():5905-15. PubMed ID: 18508631
    [Abstract] [Full Text] [Related]

  • 8. Computational and experimental studies of the interaction between phospho-peptides and the C-terminal domain of BRCA1.
    Anisimov VM, Ziemys A, Kizhake S, Yuan Z, Natarajan A, Cavasotto CN.
    J Comput Aided Mol Des; 2011 Nov 01; 25(11):1071-84. PubMed ID: 22086652
    [Abstract] [Full Text] [Related]

  • 9. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.
    Shiozaki EN, Gu L, Yan N, Shi Y.
    Mol Cell; 2004 May 07; 14(3):405-12. PubMed ID: 15125843
    [Abstract] [Full Text] [Related]

  • 10. Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk.
    Petitalot A, Dardillac E, Jacquet E, Nhiri N, Guirouilh-Barbat J, Julien P, Bouazzaoui I, Bonte D, Feunteun J, Schnell JA, Lafitte P, Aude JC, Noguès C, Rouleau E, Lidereau R, Lopez BS, Zinn-Justin S, Caputo SM, UNICANCER Genetic Group BRCA network.
    Mol Cancer Res; 2019 Jan 07; 17(1):54-69. PubMed ID: 30257991
    [Abstract] [Full Text] [Related]

  • 11. Cell signaling. The BRCT domain: signaling with friends?
    Caldecott KW.
    Science; 2003 Oct 24; 302(5645):579-80. PubMed ID: 14576410
    [No Abstract] [Full Text] [Related]

  • 12. Structure of BRCA1-BRCT/Abraxas Complex Reveals Phosphorylation-Dependent BRCT Dimerization at DNA Damage Sites.
    Wu Q, Paul A, Su D, Mehmood S, Foo TK, Ochi T, Bunting EL, Xia B, Robinson CV, Wang B, Blundell TL.
    Mol Cell; 2016 Feb 04; 61(3):434-448. PubMed ID: 26778126
    [Abstract] [Full Text] [Related]

  • 13. Cancer predisposing mutations in BRCT domains.
    di Masi A, Gullotta F, Cappadonna V, Leboffe L, Ascenzi P.
    IUBMB Life; 2011 Jul 04; 63(7):503-12. PubMed ID: 21698754
    [Abstract] [Full Text] [Related]

  • 14. Targeting Phosphopeptide Recognition by the Human BRCA1 Tandem BRCT Domain to Interrupt BRCA1-Dependent Signaling.
    Periasamy J, Kurdekar V, Jasti S, Nijaguna MB, Boggaram S, Hurakadli MA, Raina D, Kurup LM, Chintha C, Manjunath K, Goyal A, Sadasivam G, Bharatham K, Padigaru M, Potluri V, Venkitaraman AR.
    Cell Chem Biol; 2018 Jun 21; 25(6):677-690.e12. PubMed ID: 29606576
    [Abstract] [Full Text] [Related]

  • 15. Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
    Ekblad CM, Friedler A, Veprintsev D, Weinberg RL, Itzhaki LS.
    Protein Sci; 2004 Mar 21; 13(3):617-25. PubMed ID: 14978302
    [Abstract] [Full Text] [Related]

  • 16. Kinetic analysis of interaction of BRCA1 tandem breast cancer c-terminal domains with phosphorylated peptides reveals two binding conformations.
    Nominé Y, Botuyan MV, Bajzer Z, Owen WG, Caride AJ, Wasielewski E, Mer G.
    Biochemistry; 2008 Sep 16; 47(37):9866-79. PubMed ID: 18717574
    [Abstract] [Full Text] [Related]

  • 17. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
    Tischkowitz M, Hamel N, Carvalho MA, Birrane G, Soni A, van Beers EH, Joosse SA, Wong N, Novak D, Quenneville LA, Grist SA, kConFab, Nederlof PM, Goldgar DE, Tavtigian SV, Monteiro AN, Ladias JA, Foulkes WD.
    Eur J Hum Genet; 2008 Jul 16; 16(7):820-32. PubMed ID: 18285836
    [Abstract] [Full Text] [Related]

  • 18. Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1.
    Shen Y, Tong L.
    Biochemistry; 2008 May 27; 47(21):5767-73. PubMed ID: 18452305
    [Abstract] [Full Text] [Related]

  • 19. Impact of BRCA1 BRCT domain missense substitutions on phosphopeptide recognition.
    Coquelle N, Green R, Glover JN.
    Biochemistry; 2011 May 31; 50(21):4579-89. PubMed ID: 21473589
    [Abstract] [Full Text] [Related]

  • 20. Structural characterization of BRCT-tetrapeptide binding interactions.
    Joseph PR, Yuan Z, Kumar EA, Lokesh GL, Kizhake S, Rajarathnam K, Natarajan A.
    Biochem Biophys Res Commun; 2010 Mar 05; 393(2):207-10. PubMed ID: 20122900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.